Company / Cash per Share
Arcus Biosciences, Inc. Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$2.41
FY2025
5-year range
$1.74 / $2.91
FY2021-FY2025
Trend
+21.2%
vs FY2024
Sector context
#88 of 205
Health Care
What the data says
At $2.41, Arcus Biosciences, Inc.'s cash per share ranks #88 of 205 in the Health Care sector. Cash per Share has fluctuated over the past 10 years, ranging from $1.30 in FY2019 to $75.42 in FY2016.
Based on SEC 10-K filings.
2.41 in FY2025 with a 5-year CAGR of -8.6%.
Improved from $1.74 to $2.41 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -6.1%
- 5-Year CAGR
- -8.6%
- 10-Year CAGR
- -
Sector benchmark
#88 of 205 in Health CareTop 43% of 205This company $2.41 Sector average $72.93
▼
-96.7% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 21.2% year-over-year.
- Ranks #88 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2016.
- Lowest cash per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -0.93 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.41 | +21.2% |
| FY2024 | $1.99 | +14.0% |
| FY2023 | $1.74 | -40.1% |
| FY2022 | $2.91 | +28.0% |
| FY2021 | $2.27 | -39.8% |
| FY2020 | $3.78 | +190.3% |
| FY2019 | $1.30 | -92.5% |
| FY2018 | $17.37 | -67.7% |
| FY2017 | $53.84 | -28.6% |
| FY2016 | $75.42 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026